A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Ciudad De Buenos Aires, Argentina
-
Mendoza, Argentina
-
-
Buenos Aires
-
Capitol Federal, Buenos Aires, Argentina
-
-
Rosario
-
Santa Fe, Rosario, Argentina
-
-
-
-
New South Wales
-
Bankstown, New South Wales, Australia
-
Kingswood Penrith, New South Wales, Australia
-
Wollongong, New South Wales, Australia
-
-
Queensland
-
Southport, Queensland, Australia
-
-
Victoria
-
Fitzroy, Victoria, Australia
-
Frankston, Victoria, Australia
-
-
-
-
-
Innsbruck, Austria
-
St. Veit Glan, Austria
-
Wien, Austria
-
-
-
-
-
Brussels, Belgium
-
Gent, Belgium
-
Leuven, Belgium
-
-
-
-
-
Cali, Colombia
-
-
-
-
-
Lille Cedex, France
-
Marseille, France
-
Paris Cedex 10, France
-
Paris Cedex 13, France
-
Rennes Cedex, France
-
Rouen Cedex, France
-
Toulouse Cedex, France
-
-
Cedex
-
Strasbourg, Cedex, France
-
-
-
-
-
Berlin, Germany
-
Bremerhaven, Germany
-
Frankfurt, Germany
-
Kaiserslautern, Germany
-
Karlsruhe, Germany
-
Magdeburg, Germany
-
Mannheim, Germany
-
Munchen, Germany
-
Neustadt/Suedharz, Germany
-
Stuttgart, Germany
-
-
Nordhein-Westfalen
-
Bielefeld, Nordhein-Westfalen, Germany
-
-
-
-
-
Ioannina, Greece
-
-
Athens
-
Maroussi, Athens, Greece
-
-
-
-
-
Genova, Italy
-
Ravenna, Italy
-
Roma, Italy
-
-
-
-
-
Breda, Netherlands
-
Den Haag, Netherlands
-
Enschede, Netherlands
-
Roermond, Netherlands
-
Sittard, Netherlands
-
-
-
-
-
Chiclayo, Peru
-
Lima, Peru
-
-
-
-
-
Lisboa, Portugal
-
Porto, Portugal
-
Santa Maria Da Feira, Portugal
-
Santarem, Portugal
-
-
-
-
-
Barcelona, Spain
-
Madrid, Spain
-
Santa Cruz De Tenerife, Spain
-
Zaragoza, Spain
-
-
Alicante
-
Elche, Alicante, Spain
-
-
-
-
-
Linkoping, Sweden
-
Lund, Sweden
-
Malmo, Sweden
-
Stockholm, Sweden
-
Umea, Sweden
-
-
-
-
-
Tainan, Taiwan
-
Taipei, Taiwan
-
-
Kuei-Shan
-
Tao-Yuan, Kuei-Shan, Taiwan
-
-
Tainan
-
Yungkang City, Tainan, Taiwan
-
-
-
-
-
Manchester, United Kingdom
-
-
Avon
-
Bristol, Avon, United Kingdom
-
-
East Yorkshire
-
Hull, East Yorkshire, United Kingdom
-
-
London
-
Acton, London, United Kingdom
-
-
Middlesex
-
Northwood, Middlesex, United Kingdom
-
-
Northern Ireland
-
Belfast, Northern Ireland, United Kingdom
-
-
-
-
Alabama
-
Huntsville, Alabama, United States
-
-
California
-
Fountain Valley, California, United States
-
Fullerton, California, United States
-
Lancaster, California, United States
-
Los Angeles, California, United States
-
Pomona, California, United States
-
Santa Rosa, California, United States
-
Torrance, California, United States
-
-
Colorado
-
Fort Collins, Colorado, United States
-
-
Connecticut
-
Hartford, Connecticut, United States
-
-
Florida
-
Lake Worth, Florida, United States
-
Miami, Florida, United States
-
-
Illinois
-
Chicago, Illinois, United States
-
Decatur, Illinois, United States
-
Harvey, Illinois, United States
-
-
Indiana
-
Indianapolis, Indiana, United States
-
-
Kansas
-
Wichita, Kansas, United States
-
-
Kentucky
-
Crestview Hills, Kentucky, United States
-
Louisville, Kentucky, United States
-
-
Louisiana
-
Lafayette, Louisiana, United States
-
Shreveport, Louisiana, United States
-
-
Maine
-
Scarborough, Maine, United States
-
-
Massachusetts
-
Burlington, Massachusetts, United States
-
-
Nebraska
-
Omaha, Nebraska, United States
-
-
New Mexico
-
Albuquerque, New Mexico, United States
-
-
New York
-
New York, New York, United States
-
-
Ohio
-
Canton, Ohio, United States
-
Cleveland, Ohio, United States
-
-
Pennsylvania
-
Drexel Hill, Pennsylvania, United States
-
Pittsburgh, Pennsylvania, United States
-
-
South Carolina
-
Charleston, South Carolina, United States
-
Columbia, South Carolina, United States
-
-
Tennessee
-
Johnson City, Tennessee, United States
-
Memphis, Tennessee, United States
-
Nashville, Tennessee, United States
-
-
Texas
-
San Antonio, Texas, United States
-
Tyler, Texas, United States
-
-
Washington
-
Tacoma, Washington, United States
-
-
Wisconsin
-
Marshfield, Wisconsin, United States
-
Milwaukee, Wisconsin, United States
-
-
-
-
-
Caracas, Venezuela
-
-
Edo. Aragua
-
Valencia, Edo. Aragua, Venezuela
-
-
Maracay
-
Estado Aragua, Maracay, Venezuela
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pancreas cancer that cannot be removed by surgery OR that has spread to a new site in your body.
- You must have one tumor that can be physically measured or scanned by the doctor.
- You have not had any chemotherapy, immunotherapy, biologic therapy, or hormonal therapy for pancreas cancer, including 5-FU.
- You cannot have any radiation for 4 weeks before starting this study, and you cannot have radiation to the whole pelvis.
Exclusion Criteria:
- Treatment with any medication or device that has not been approved by regulatory agencies, like the FDA, at the time you enter the study.
- Documentation that the cancer has spread to your brain.
- Pregnant or breastfeeding.
- A second primary cancer.
- Unable to stop aspirin or non-steroidal anti-inflammatory agents (like ibuprofen) for 5-8 days.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Neoplasms by Site
- Endocrine System Diseases
- Digestive System Neoplasms
- Endocrine Gland Neoplasms
- Neoplastic Processes
- Pancreatic Diseases
- Neoplasms
- Neoplasm Metastasis
- Pancreatic Neoplasms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Antiviral Agents
- Nucleic Acid Synthesis Inhibitors
- Enzyme Inhibitors
- Antimetabolites, Antineoplastic
- Antimetabolites
- Antineoplastic Agents
- Immunosuppressive Agents
- Immunologic Factors
- Folic Acid Antagonists
- Gemcitabine
- Pemetrexed
Other Study ID Numbers
Other Study ID Numbers
- 5148
- H3E-MC-JMES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.